%0 Journal Article
%A Mao, Ziling
%A Baker, Jacqueline Roshelli
%A Takeuchi, Masayoshi
%A Hyogo, Hideyuki
%A Tjønneland, Anne
%A Eriksen, Anne Kirstine
%A Severi, Gianluca
%A Rothwell, Joseph
%A Laouali, Nasser
%A Katzke, Verena
%A Kaaks, Rudolf
%A Schulze, Matthias B
%A Palli, Domenico
%A Sieri, Sabina
%A de Magistris, Maria Santucci
%A Tumino, Rosario
%A Sacerdote, Carlotta
%A Derksen, Jeroen W G
%A Gram, Inger T
%A Skeie, Guri
%A Sandanger, Torkjel M
%A Quirós, Jose Ramón
%A Crous-Bou, Marta
%A Sánchez, Maria-Jose
%A Amiano, Pilar
%A Colorado-Yohar, Sandra M
%A Guevara, Marcela
%A Harlid, Sophia
%A Johansson, Ingegerd
%A Perez-Cornago, Aurora
%A Freisling, Heinz
%A Gunter, Marc
%A Weiderpass, Elisabete
%A Heath, Alicia K
%A Aglago, Elom
%A Jenab, Mazda
%A Fedirko, Veronika
%T Pre-diagnostic Serum Glyceraldehyde-Derived Advanced Glycation End Products and Mortality Among Colorectal Cancer Patients.
%J International journal of cancer
%V 152
%N 11
%@ 0020-7136
%C Bognor Regis
%I Wiley-Liss
%M DKFZ-2023-00237
%P 2257-2268
%D 2023
%Z 2023 Jun 1;152(11):2257-2268
%X Glyceraldehyde-derived advanced glycation end products (glycer-AGEs) could contribute to colorectal cancer development and progression due to their pro-oxidative and pro-inflammatory properties. However, the association of glycer-AGEs with mortality after colorectal cancer diagnosis has not been previously investigated. Circulating glycer-AGEs were measured by competitive ELISA. Multivariable Cox proportional hazards models were used to calculate hazard ratios (HRs) and corresponding 95
%K Glyceraldehyde-derived advanced glycation end products (Other)
%K advanced glycation end products (Other)
%K colorectal cancer (Other)
%K mortality (Other)
%K prospective study (Other)
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:36715363
%R 10.1002/ijc.34449
%U https://inrepo02.dkfz.de/record/212552